Company intelligence / Profile preview
Changchun Lanjiang Pharmaceutical Technology
- Ownership
- Private
- Development stage
- Other
Overview
Changchun Lanjiang Pharmaceutical Technology is a clinical-stage biotechnology company based in Changchun, China, specializing in the discovery and development of innovative small molecule therapeutics. Established in 2013, the company focuses primarily on metabolic and endocrine disorders, including type 2 diabetes and hyperuricemia. Its lead program, LJ-101, is a GPR119 agonist currently in Phase 2 clinical trials for diabetes management. Additionally, the company is advancing LJ-401, a URAT1 inhibitor for the treatment of gout and hyperuricemia, alongside other early-stage metabolic programs.
- Therapeutic areas
- EndocrinologyRheumatologyCardiovascularMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Changchun Lanjiang Pharmaceutical Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Changchun Lanjiang Pharmaceutical Technology.